Reactivate STING-interferon (IFN) signaling to restore anti-tumor immunity;Re-release STING-IFN signals to recruit T cells and natural killer (NK), cells that are sensitive to NK cell-derived IFN γ;The combination of TREX1 inhibitor and PD-1 can enhance immunogenicity. Here, STING1 is linked to neoplasm.